Introduction
Death receptors (DRs) and their ligands are expressed in the nervous system, particularly during development (Park et al., 1998; Neumann et al., 2002; Shin et al., 2002; Choi and Benveniste, 2004 ). However, they do not seem to play a major role regulating physiological neuronal death except in certain populations such as the motoneurons (Raoul et al., 1999 (Raoul et al., , 2000 (Raoul et al., , 2002 . The activation of DRs can alternatively induce cell survival or differentiation through the nuclear factor B (NF-B) or the extracellular-regulated kinase (ERK) signaling pathways (Desbarats et al., 2003; Marchetti et al., 2004) . In this way, DRs could regulate neuronal plasticity during the development of the nervous system (Cheema et al., 1999; Martin-Villalba et al., 1999; Desbarats et al., 2003; Zuliani et al., 2006) . They were also involved in pathological neuronal death: Fas in spinal cord injury (Demjen et al., 2004; Yoshino et al., 2004; Casha et al., 2005; Ackery et al., 2006) , or Fas and tumor necrosis factor (TNF) in axotomy-induced motoneuron death (Ugolini et al., 2003) and ischemia-induced brain damage (Martin-Villalba et al., 1999 Graham et al., 2004) DR activity can be regulated (blocked) by anti-apoptotic proteins such as c-FLIP (FLICE-inhibitory protein), C-IAP-1/2 (cellular inhibitor of apoptosis-1/2), or the anti-apoptotic members of the Bcl-2 family (Liston et al., 1997; Tschopp et al., 1998; Desagher and Martinou, 2000) . However, emerging evidence shows that other DR-regulatory molecules are expressed in the nervous system, such as Lifeguard (LFG) or PEA-15 (phosphoprotein enriched in astrocytes-15 kDa) (Boldin et al., 1995; Somia et al., 1999; Fernández et al., 2007) .
Fas apoptosis inhibitory molecule (FAIM) was characterized as an inhibitor of Fas that was upregulated in B-cells resistant to Fas-mediated cell death (Schneider et al., 1999) . Later, an alternative spliced form containing 22 aa longer at the N terminus was reported and named FAIM long (FAIM L ) (Zhong et al., 2001 ). FAIM S is widely expressed, whereas FAIM L is almost exclusively expressed in the nervous system. We reported previously that FAIM S , but not FAIM L , overexpression greatly enhances neurite outgrowth in PC12 (pheochromocytoma cell line) cells and primary neurons through the NF-B and mitogen-activated protein kinase (MAPK)/ERK pathways . Nonetheless, the physiological role of FAIM L remains so far to be elucidated.
Here, we provide for the first time evidence that FAIM L in vivo is highly expressed by neurons in diverse areas of the brain. Moreover, FAIM L levels are regulated during neuronal differentiation, both in vivo and in vitro, and the ERK pathway seems to be an important regulator of its expression after NGF stimulation. Ectopically overexpressed FAIM L blocks Fas and TNF-induced cell death in both PC12 cells and cortical neurons. Specific knockdown of endogenous FAIM L transcript renders PC12 cells and primary neurons (cortical neurons and motoneurons) sensitive to the proapoptotic action of FasL and TNF-␣. FAIM L , but not FAIM S , is able to bind nonstimulated Fas in coimmunoprecipitation experiments. Binding could be displaced by FASassociated death domain (FADD) overexpression, indicating that FAIM L and FADD compete for Fas binding. When Fas is stimulated by FasL, the interaction between Fas and FAIM L is no longer observed. Altogether, our results place FAIM L as a novel endogenous antagonist regulating DR-mediated neuronal cell death.
Materials and Methods
Reagents. Purified recombinant human NGF was obtained from Genentech (San Francisco, CA), and mouse 7S NGF was prepared from male submandibular salivary glands as described previously (Mobley et al., 1976) . Anti-phospho-ERK1/2 was obtained from Cell Signaling Technology (Beverly, MA). Anti-pan-ERK was obtained from BD Transduction Laboratories (San Diego, CA). Anti-FLAG M2, apoptosis-inducing factor (AIF), and ␣-tubulin were obtained from Sigma (St. Louis, MO). Anti-histone H1 was obtained from Stressgen (Ann Arbor, MI). Anti-Fas was obtained from Santa Cruz Biotechnology (Santa Cruz, CA). A rabbit polyclonal anti-FAIM antibody was characterized previously in our laboratory . All biochemicals were obtained from SigmaAldrich unless otherwise indicated.
Cell culture. PC12 cells were cultured in DMEM supplemented with 6% heat-inactivated fetal calf serum, 6% heat-inactivated horse serum (HS) (Invitrogen, Paisley, UK), 10 mM HEPES, 20 U/ml penicillin, and 20 g/ml streptomycin.
Primary cortical neurons were dissected from embryonic day 16 (E16) mice (unless otherwise indicated) and cultured as described previously (Iglesias et al., 2003) . Cells were plated in 10 g/ml poly-D-lysine-coated culture plates and cultured in DMEM supplemented with 10% HS. After 4 h, medium was replaced with serum-free DMEM supplemented with B27 (Invitrogen) and N2 (Invitrogen).
Spinal cord motoneurons (MTNs) were purified from E12.5 mice according to Arce et al. (1998) and Comella et al. (1994) , with minor modifications. Briefly, spinal cords were dissected from mouse embryo, trypsinized (Sigma) for 7 min at 37°C, and dissociated and collected under a bovine serum albumin (BSA) cushion. The MTNs were then isolated by OptiPrep density gradient centrifugation (10 min at 520 ϫ g).
After a final centrifugation through a BSA cushion, MTNs were resuspended in neurobasal medium supplemented with 2% horse serum, B27, 0.5 mM L-glutamine, 25 M 2-mercaptoetanol, and 10 ng/ml BDNF (Alomone Labs, Jerusalem, Israel) and plated in poly-ornithine/laminincoated four-well plates (Nunc, Rochester, NY) at a density of 5 ϫ 10 3 -1 ϫ 10 4 cells per well. All cultures were maintained at 37°C in a saturated humidified atmosphere of 95% air and 5% CO 2 .
Anti-FAIM L antibody production. A rabbit polyclonal antibody was generated according to standard protocols (Harlow, 1988) . The immunogenic peptide used was SGDDSPIFEDDESPLC (amino acids 3-18) and corresponds to a part of the differential sequence between FAIM L and FAIM S isoforms.
Plasmids. Rat FAIM L was expressed under the control of a cytomegalovirus constitutive promoter in the pcDNA3 expression vector (Invitrogen) as described previously . cDNAs containing ORFs of FADD, and murine Fas were subcloned into a vector holding a C-terminal hemaglutinin epitope (HA) or pcDNA3, respectively.
For RNA interference (RNAi) experiments, constructs were obtained into the pSUPER.retro.puro plasmid (OligoEngine, Seattle, WA) using specific oligonucleotides of the FAIM sequence, indicated by capital letter, as follows, RNAi n°1, which is specific for FAIM L (forward), gatccccGATGTTCAAATTGGTGGGCttcaagagaGCCCACCAATTTGAACATCttttt, and (reverse) agctaaaaaGATGTTCAAATTGGTGGGCtctcttgaaGCCCACCAATTTGAACATCggg. RNAi n°2, which is specific for FAIM S (forward), gatccccGGCAAACGAGTTGTGTACGttcaagagaCGTACACAACTCGTTTGCCttttt, (reverse) agctaaaaaGGCAAACGAGTTGTGTACGtctcttgaaCGTACACAACTCGTTTGCCggg. Oligonucleotides were obtained from Sigma and were cloned between BglII/HindIII sites of pSUPER.retro.puro plasmid. Lentiviral constructs were achieved by digesting EcoR1-ClaI sites from pSUPER-sh to replace H1 promoter with H1-shRNA cassette in pLVTHM.
Production of lentiviral particle. Lentiviruses were propagated using methods described previously (Naldini et al., 1996; Zufferey et al., 1998) . Briefly, human embryonic kidney 293T (HEK293T) cells were seeded at a density of 2.5 ϫ 10 6 cells in 0.1% gelatin-coated 100 mm dishes. The following day, cells were transfected with 20 g of pLVTHM or pWPI derived constructs, 13 g of pSPAX2, and 7 g of pM2G. The transfection was routinely performed by the calcium phosphate transfection method (Cullen, 1987) . Cells were allowed to produce lentiviruses for 48 h. After 48 h, the medium was centrifuged at 1200 ϫ g for 5 min, and the supernatant was filtered using 45 m filters. Lentiviruses were concentrated at 50,000 ϫ g for 90 min and then resuspended in 20 l of PBS containing 1% BSA. Lentiviruses were stored at Ϫ80°C. Biological titers of the viral preparations expressed as a number of transducing units per milliliter (TU/ml) were determined by transducing HEK293T cells in limiting dilutions. After 48 h of incubation, the percentage of green fluorescent protein (GFP)-positive cells was counted and viruses at 5 ϫ 10 8 -1 ϫ 10 9 TU/ml were used in the experiments. Cell transfection and transduction. Unless otherwise indicated, PC12 cells were transfected with the desired expression plasmid using Lipofectamine 2000 (Invitrogen) according to suggested manufacturer procedures. Pools of cells transfected with FAIM L , FAIM S , or empty pcDNA3 were obtained by adding 500 g/ml G418 (Geneticin) to the culture medium (Invitrogen).
For lentiviral-based knock-down experiments, cells were seeded in 24-multiwell plates at a density of 2 ϫ 10 4 cells/well for PC12 cells, 1 ϫ 10 5 for cortical neurons, or 5-10 ϫ 10 3 for MTNs. Concentrated lentiviruses were added to the medium (minimum multiplicity of infection, 5). After 4 h, the medium was changed and the infection efficiency was monitored in each experiment by direct counting of GFP-positive cells. The percentage of infection reached to 80% for cortical neurons [3 d in vitro (DIV)] and MTNs (5DIV) and 99% for PC12 cells.
Western blot analysis. Cells were rinsed in ice-cold PBS, pH 7.2, after stimulation. Cell lysate was harvested with 2% SDS-125 mM Tris/HCl, pH 6.8, and protein concentration was quantified by a modified Lowry assay (Bio-RadDc protein assay; Bio-Rad, Hercules, CA). Cell lysates (10 -25 g of protein) were resolved in SDS-PAGE and transferred onto polyvinylidene difluoride (PVDF) Immobilon-P membranes (Millipore, Bedford, MA) using a semidry transfer unit (Hoefer Pharmacia Biotech, San Francisco, CA). After blocking with Tris-buffered saline with Tween-20 containing 5% nonfat dry milk for 1 h at room temperature, the membranes were probed with the appropriate primary antibodies according to the specific requirements indicated by each provider. After 1 h of incubation with the specific peroxidase-conjugated secondary antibodies, the membranes were developed with the EZ-ECL chemiluminescence detection kit (Biological Industries, Kibbutz Beit Haemek, Israel) .
Reverse transcription-PCR analysis. Reverse transcription (RT)-PCR was essentially performed using standard protocols . Briefly, cDNA was reverse-transcribed from RNA of adult mice tissues and PC12 cells with the RNeasy kit according to the manufactured instructions (Qiagen, Valencia, CA). PCR was performed by amplification of FAIM L , FAIM S , and the housekeeping L27 ribosomal protein cDNAs in a PerkinElmer (Emeryville, CA) thermal cycler 2400. Primers used to amplify 189 and 246 bp specific fragments corresponding to FAIM S and FAIM L , respectively, were: GACAGCTGCTGACTACGTCG (forward) and TCCTTCCCATCCACGTACAC (reverse). Primers used to specifically amplify the 246 bp fragment corresponding to FAIM L were: CGGGATCCCTGGCGTCTGGAGATGACAGT (forward) and TCCTTCCCATCCACGTACAC (reverse). L27 primers were: AGCTGT-CATCGTGAAGAA (forward) and CTTGGCGATCTTCTTCTTGCC (reverse).
Immunofluorescence. E15 cortical neurons at 1 DIV were transfected with pcDNA3-FAIM L using Lipofectamine 2000 (Invitrogen) with the desired constructs and 48 h later were rinsed with PBS at room temperature and fixed in 4% paraformaldehyde/PBS for 30 min at room temperature. Then, they were washed twice with PBS and subsequently permeabilized and blocked with 5% bovine serum albumin and 0.1% Triton X-100 in PBS for 60 min at room temperature. The cells were incubated overnight with monoclonal anti-FLAG, rinsed three times with PBS, and incubated with anti-rabbit secondary antibodies conjugated with Alexa Fluor 488 (Invitrogen, Eugene OR) for 1 h at room temperature protected from light. Confocal micrographs were obtained using an inverted Olympus XT FV500 microscope (Olympus Optical, Tokyo, Japan).
For the active caspase-3 immunofluorescence, cells were fixed and permeabilized as indicated above and then incubated overnight at 4°C with a polyclonal anti-cleaved Caspase-3 (Cell Signaling Technology) diluted 1:150, rinsed three times with PBS, and incubated with antirabbit secondary antibodies conjugated with Alexa Fluor 594 (Invitrogen) diluted 1:250 for 1 h at room temperature protected from light. Finally, cells were stained with 0.05 g/ml Hoechst 33258 for 30 min. Representative micrographs were obtained using an inverted Olympus XT.
Immunohistochemistry. E16, E18, postnatal day 0 (P0), P5, P10, and adult (P60) OF-1 mice (Charles River, Lyon, France) were used for the immunohistochemistry experiments. The day when the vaginal plug was detected was considered E0 and the day of birth as P0. First, the animals were deeply anesthetized with a mixture of Ketolar (Parke-Davies/Pfizer New York, NY)/Rompun (Bayer, Leverkusen, Germany) and perfused with 4% paraformaldehyde. The brains were removed, cryoprotected, and frozen. Thirty to 50 m coronal sections were obtained. After blocking, sections were incubated overnight with specific rabbit antibody against FAIM L (1:600). This primary antibody was visualized by sequential incubation with biotinylated secondary antibodies (1:200; Vector Laboratories, Burlingame, CA) and the streptavidine-peroxidase complex (1:400; Amersham Biosciences, Pittsburgh, PA). The peroxidase reaction was developed with diaminobenzidine and H 2 O 2 . Sections were mounted onto gelatinized slides, dehydrated, and coverslipped with DPX (a mixture of distyrene, tricresyl phosphate, and xylene).
Sections from E16, P5, and adult mice were used for double immunofluorescence studies. After blocking, sections were incubated overnight with the specific rabbit antibody detecting FAIM L (1:600) combined with mouse monoclonal antibodies against neuronal-specific nuclear protein (NeuN) (1:100; Chemicon, Temecula, CA), calbindin, or parvalbumin (Calb 1:5000; Parv, 1:2000; Swant, Bellinzona, Switzerland), GFAP (1: 500; Chemicon), or with a rat monoclonal antibody against CD31 (1:10; BD PharMingen, San Diego, CA). Primary antibodies were visualized using secondary Alexa Fluor-conjugated antibodies. Sections were counterstained with Bisbenzimide, mounted onto slides, and viewed under confocal microscopy. Some sections were also incubated with preimmune serum (1:600) and processed as above.
FAIM promoter assay. The predicted promoter of FAIM was amplified from rat genomic DNA using the primers 5Ј-TCCCCCGGGCTC-TGCCAAACACCCTGATTTG-3Ј (forward) and 5Ј-CCGCTCGAGCC-CAGCCTCCTACTGCCTTCC-3Ј (reverse). The amplified fragment (2.2 kbp) was subcloned into pGL3-basic (Promega, Mannheim, Germany). For the assay, PC12 cells were seeded into 24-well plates and transfected with the pGL3-empty or pGL3-2.2 kbp vectors. Twenty-four hours later, cells were treated as indicated. After an additional 24 h, cells were lysed with the Cell Culture Lysis Reagent (Luciferase Assay System Kit; Promega). The activity of firefly luciferase was determined using a FB12 Luminometer (Berthold, Bundoora, Australia). Aliquots of supernatant were transferred to a standard 96-well plate for protein concentration determination by the Lowry method (Bio-Rad) following the manufacturer instructions. Luciferase values were normalized in respect to protein concentration (RLU/g of protein).
Assessment of cell survival and apoptotic cell death. A total of 1 ϫ 10 6 PC12 cells were infected with lentivirus carrying indicated constructs and 48 h later were split in 24-well plates (2 ϫ 10 4 cells/well) in triplicate. Twenty hours later, cells were treated with sFasL (100 ng/ml), TNF␣ (100 ng/ml) plus 1 nM ActD for 24 h, or left untreated. For mouse primary cultures, neurons were transduced as described above and treated with Jo2 (5 g/ml) at 3 DIV for cortical neurons and 5 DIV for motoneurons. Apoptotic cell death was measured 24 h later by counting apoptotic nuclei after Hoechst 33258 nuclear staining according to Yuste et al. (2005) . Experiments were repeated at least three times, and a minimum of 500 cells were counted per condition. Apoptosis was also assessed by TUNEL staining. To this end, cells were fixed in 4% paraformaldehyde/ PBS for 60 min at room temperature, permeabilized with 0.1% Triton X-100 in 0.1% Sodium Citrate for 2 min at 4°C, and processed following the In Situ Cell Death Detection Kit instructions (Roche Products, Welwyn Garden City, UK). For the final step, Hoechst 33258 was added at 0.05 g/ml. The cell death was scored by counting positively stained apoptotic nuclei using an Olympus microscope equipped with epifluorescence optics. When necessary, cell viability was determined by the alamarBlue assay following the manufacturer instructions (Biosource, Camarillo, CA).
Fluorogenic caspase activities. Caspase activity determination was performed as described previously (Yuste et al., 2001) . The assays were performed using 150 M fluorogenic substrate Ac-IETD-afc (caspase-8-directed activities) or 50 M Ac-DEVD-afc (caspase-3-like activities). The plates were read in a Bio-Tek (Izasa, Spain) FLx800 Fluorimeter using a 360 nm (40 nm bandwidth) excitation filter and a 530 nm (25 nm bandwidth) emission filter.
Neurite measurement. PC12 cells were infected with lentivirus RS, R1, and R2 for 72 h and then washed and transferred to poly-D-lysine/ collagen-coated 35 mm dishes at a density of 1 ϫ 10 5 cells per dish. Twenty-four hours later, complete medium was replaced with medium containing NGF (100 ng/ml) with 0.5% of horse serum. Photographs of random fields were taken 1 d later by using an inverted microscope (Olympus) equipped with epifluorescence optics coupled with a digital camera (OM-4 Ti; Olympus). Neurite outgrowth was measured using the Adobe Photoshop 6.0 software (Adobe Systems, San Jose, CA). In every experiment, a minimum of 100 cells were measured per condition.
NF-B activity. NF-B activity was measured as described previously . Briefly, PC12 cells were seeded in 24-well plates at a density of 1 ϫ 10 5 cells/well. Cells were transfected with 0.5 g/well of the NF-kB-dependent reporter vector (HIV-LTR-Luciferase). Twenty four hours later, cells were stimulated with 100 ng/ml NGF for 6 h. The activity of firefly luciferase was determined as described above. The NFkB-dependent reporter vector (HIV-LTR-luciferase) was obtained from R. Hay (University of St Andrews, Fife, Scotland).
Coimmunoprecipitation. For coimmunoprecipitation (CoIP) experiments, 3 ϫ 10 6 HEK293T cells were seeded on 150 mm tissue culture dishes and transfected using the calcium phosphate method (Cullen, 1987) with pEYFP (Clontech), pcDNA3-FAIM L -FLAG or pcDNA3-FAIM S -FLAG constructs. PC12 cells seeded onto 150 mm tissue culture dishes were transfected using Lipofectamine 2000 with pEYFP (Clontech), pcDNA3-FAIM L -FLAG, pcDNA3-FAIM S -FLAG, HA-FADD, or pcDNA3-mFas constructs. When indicated, cells were stimulated with sFasL, 24 h posttransfection. After 2 d posttransfection, cells were harvested in lysis buffer CoIP (20 mM Tris/HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 10% Glycerol, 1% Triton X-100) supplemented with a protease inhibitor mixture (Roche Diagnostics). Lysates were clarified by centrifugation and quantified by the Lowry assay (Bio-Rad). One milligram of total protein was taken and adjusted with the CoIP buffer to achieve a final concentration of 1 g/l. Forty microliters of anti-FLAG M2-agarose-coupled antibody were added to each sample and incubated overnight at 4°C in an orbital shaker. Then, beads were washed five times with CoIP buffer and eluted for 30 min at 4°C with 50 l of TBS containing 150 ng/ml of 3xFLAG competitor peptide (Sigma). After a short spin, supernatants were carefully taken, Laemli's-loading buffer was added, and SDS-PAGE was performed.
Alternatively, 1 mg of cleared supernatant from PC12 cells was subjected to immunoprecipitation with 2 g of an anti-Fas antibody overnight at 4°C. Antibodies were recovered with protein-G and resolved in SDS-PAGE.
Results

FAIM L is a cytosolic protein predominantly expressed in neurons
With the aim to study FAIM L expression and distribution, as well as to explore its functional role, we first developed a specific rabbit polyclonal antibody. Because the differential sequence between FAIM S and FAIM L is 22 aa at the N terminus of the protein, 16 of these 22 were selected as an antigen. To demonstrate antibody specificity, we analyzed the expression of FAIM L in lysates from brain (positive control) and liver (used as a negative control). The antibody recognized a single immunoreactive band only in brain lysates with an apparent molecular weight of ϳ23 kDa (supplemental Fig. 1 A, right panel, available at www.jneurosci.org as supplemental material) that was absent when the membrane was blotted using the preimmune serum (supplemental Fig. 1 A, middle panel, available at www.jneurosci.org as supplemental material). We further confirmed that the ϳ23 kDa band indeed corresponds to FAIM L by transient transfection of HEK293T cells with increasing amounts of N-terminally FLAG-tagged FAIM L . Duplicate samples were loaded in a gel; one set of samples was blotted with anti-FLAG (supplemental Fig. 1 B, left panel, available at www.jneurosci.org as supplemental material) and the other with anti-FAIM L (supplemental Fig. 1 B, right panel, available at www.jneurosci.org as supplemental material). Both antibodies recognize the same band with enhanced intensity corresponding to the increasing amounts of transfected DNA (supplemental Fig. 1 B, available at www.jneurosci.org as supplemental material). Moreover, we wanted to analyze whether anti-FAIM L antibodies were able to detect the protein in nondenaturing conditions. For this purpose, we synthesized FLAG-tagged FAIM L using an in vitro reticulocyte-based transcription and translation system (Promega). Reticulocyte suspension was subjected to immunoprecipitation using the anti-FAIM L antibody. Immunoprecipitates were resolved on SDS-PAGE gels and blotted with anti-FLAG. Anti-FAIM L antibodies were able to immunoprecipitate FAIM L , whereas no signal was detected using a nonrelevant rabbit immune serum (supplemental Fig. 1C , available at www.jneurosci.org as supplemental material).
The anti-FAIM L antiserum was then used to analyze the protein expression profile in different mouse tissues. An immunoreactive band of ϳ23 kDa was detected in lysates from different brain regions such as cortex, hippocampus, and cerebellum, as well as in spinal cord. No signal was detected in heart, skeletal muscle, kidney, liver, or lung (Fig. 1 A) . RT-PCR analysis confirms identical specific FAIM L distribution in the nervous system (Fig. 1 B) . Moreover, we analyzed the expression of FAIM L in the hematopoietic/immune system, because of the high relevance of DRs in that system. FAIM L protein expression was not detected in cell lines or in primary lymphocytes but was detected in cerebral cortex lysate used as a positive control. Note that FAIM S was detected in lymphocytic cell lines (Fig. 1C) .
We next examined the subcellular distribution of FAIM L . For this purpose, PC12 cells were lysed in a hypotonic buffer and (20 g) were analyzed by SDS-PAGE/ immunoblot using anti-FAIM L serum (1:1000) (top panel). As the loading control, the membrane was stained with Naphtol Blue. B, Mouse FAIM L mRNA tissular content was assessed by semiquantitative RT-PCR with specific primers and compared with L27 housekeeping gene. C, Immunoblot analysis of the FAIM L expression in human and mouse hematopoietic/immune cells as indicated. Cortical neurons, neuroblastoma SH-SY5Y, and transfected PC12 extracts were used as a positive control of the FAIM L and total FAIM expression. Twenty micrograms of total protein were resolved by SDS-PAGE and blotted with anti-FAIM S (top panel) and FAIM L (middle panel). Naphtol blue staining was used as a loading control (bottom panel). D, PC12 cells were lysed in a hypotonic solution, and two crude subcellular fractions were prepared. The equivalent protein content of each fraction was subjected to SDS/PAGE immunoblot analysis using antibodies specific for FAIM L , pan-ERK (cytosolic marker), Histone H1 (nuclear marker), and AIF (mitochondria marker). C, Cytosolic fraction; HMϩN, heavy membrane and nuclear fraction. E, Subcellular distribution of FAIM L . Confocal microscopy (60ϫ) of E15 cortical cells transfected with FLAG-FAIM L and immunofluorescence with anti-FLAG coupled to a secondary anti-mouse conjugated to FITC. Scale bar, 20 m. CX, Cortex; CL, cerebellum; HP, hippocampus; HT, heart; SM, skeletal muscle; KD, kidney; SC, spinal cord; LV, liver; LG, lung; NB, Naphtol Blue; C, cytosolic; HM, heavy membranes; N, nuclei.
separated by centrifugation into two subcellular fractions, one containing only cytosolic proteins (C) and the other including heavy membranes and nuclei (HMϩN). FAIM L was only detected in the cytosolic fraction as determined by immunoblot analysis (Fig. 1 D, lane C) . No signal was detected in the fraction that includes membranes, mitochondria, and nucleus ( Fig. 1 D,  lane HMϩN) . By reprobing the same blots with antibodies against mitochondrial (AIF), cytosolic (ERK1/2), or nuclear (Histone H1) proteins, fractionation procedure (Fig. 1 D) was validated. To further analyze the cellular distribution of FAIM L in primary cells, we performed immunofluorescence staining of cortical neurons transiently transfected with FLAG-tagged FAIM L . Confocal microscopy shows a diffuse cytosolic pattern in the soma that excludes the nucleus (Fig. 1 E) . Neurite arbors were also positive (Fig. 1 E, inset) . We conclude therefore that FAIM L is a cytosolic soluble protein.
To characterize the expression pattern of FAIM L during the development of the CNS, we performed immunohistochemistry using the FAIM L -specific antibody. FAIM L -specific antibodies labeled neurons in most brain regions through development (Fig.  2) . In contrast, sections incubated with preimmune serum did not exhibit immunostaining (supplemental Fig. 2 A-H, available at www.jneurosci.org as supplemental material). High levels were detected in the telencephalon (cerebral cortex and hippocampus) and cerebellum. Some brain regions such as the thalamus, septum, caudate-putamen, and globus palidus also showed FAIM L immunostaining. No relevant expression of FAIM L was found in axonal tracts in any regions of the forebrain or cerebellum (data not shown). In the embryonic cerebral cortex, labeled cells were located in the cortical plate (CP) and in the subplate (SP), corresponding to postmitotic neurons in these layers (Fig. 2 A) . At P0, cortical plate neurons maintained FAIM L expression; FAIM Lpositive cells were also found in the cortical layer V (Fig. 2 B) . At P5, the cell bodies and dendrites of layer V cortical neurons exhibited strong FAIM L immunostaining (Fig. 2C) . At postnatal and adult stages, many cortical neurons in layers V and II-III showed FAIM L immunolabeling (Fig. 2 D, E) . In the embryonic hippocampus, cells in the hippocampal plate expressed FAIM L (data not shown). At postnatal stages, pyramidal neurons in CA1-3 and some interneurons through all hippocampal layers expressed FAIM L . Weak staining was seen in the granule cells of the dentate gyrus (Fig. 2 F-H ) . The distribution of FAIM Lpositive cells in the hippocampus was maintained into adulthood (data not shown). The cerebellum also showed an intense FAIM L immunolabeling. FAIM L was expressed in migratory Purkinje cells in the embryonic cerebellum (data not shown). At early postnatal stages (P5), the cell bodies of Purkinje neurons expressed high levels of FAIM L ; Purkinje cell dendrites also showed intense FAIM L immunostaining (Fig. 2 I) . In addition, at P5 and P10, some interneurons located in the internal granular layer were positive for FAIM L immunostaining (Fig. 2 J, K ) . Purkinje neurons and some cerebellar interneurons maintained the FAIM L expression at later stages and also through adulthood (Fig.  2 J-L) .
To confirm that FAIM L was expressed in neurons, sections from E16, P5, and adult brains were immunoreacted for FAIM L and distinct neural markers. Double immunolabeling with FAIM L antibodies and the pan-neuronal marker NeuN showed an almost complete colocalization of both proteins at all the developmental stages tested (Fig. 2 M-O) . Similarly, double immunolabeling with FAIM L antibodies and markers of neuronal subsets (such as calbindin and parvalbumin) (data not shown) further confirmed that FAIM L was expressed in neurons ( Fig.   2 P-R) . Finally, double immunofluorescence studies with cell markers of astroglial cells (GFAP) (supplemental Fig. 2 I-K, available at www.jneurosci.org as supplemental material), oligodendrocytes (O4) (data not shown), or endothelial cells (CD31) (supplemental Fig. 2 L-N 
FAIM L is upregulated during neuronal differentiation
To obtain quantitative expression data, we performed immunoblots with cortical tissue lysates of mouse brains from different ages. FAIM L levels were low at E12. A moderate increase was detected at E15, and maximum levels were reached at E18. Then, FAIM L levels were stabilized in the early postnatal stages and in the adult (Fig. 3A) . However, levels of FAIM S were unaltered during development. To determine whether FAIM L is expressed in differentiated cells, levels of the protein were analyzed in cultured cells. The expression of FAIM L was analyzed in cultures of cortical neurons. The FAIM L signal was low at day 0 (a few hours after plating) but increased by threefold with time in culture (Fig.  3B) . Again, levels of FAIM S were barely detectable and unchanged during the time course. Next, we analyzed the expression of FAIM in a well characterized differentiation cellular model system. As shown in Figure 3C , NGF induces an increase in FAIM L mRNA levels up to threefold in PC12 cells when compared with the untreated proliferating cells. Moreover, FAIM L protein amounts increase approximately threefold (after 1, 3, 5, or 7 d with the neurotrophin) or sixfold (after 9 d in the presence of the neurotrophin) compared with proliferating control levels (Fig. 3D) . However, mRNA and protein levels of FAIM S remain unaltered during the different days in the presence of NGF (Fig.  3C,D) .
Because FAIM L was upregulated in response to NGF in PC12 cells, we wanted to determine which signaling pathway was involved in this regulation. Because the MAPK/ERK pathway has been shown to be one of the most relevant for neurotrophininduced neuronal differentiation (Chao, 2003) , we analyzed its involvement in FAIM L regulation. As shown in Figure 3E , NGF induces a significant increase in the FAIM L protein content compared with the level observed in proliferating PC12 cells. Treatment of cultures with the microtubule-associated protein kinase kinase (MEK) inhibitor PD98059 blocked the increase of FAIM L after NGF exposure, thus indicating that the MAPK/ERK pathway was primarily responsible for FAIM L induction. To further investigate the regulation of FAIM L transcription, we cloned the rat FAIM promoter (2.2 kbp) into the luciferase reporter plasmid pGL3-basic. There was basal activation of the FAIM L reporter plasmids in PC12 cells without stimulation, probably because of the fact that PC12 cells express the short form of FAIM. Treatment with NGF further increased luciferase signal. After incubation with MEK1 inhibitor PD98059, the activity of FAIM promoter was reduced to almost nonstimulated luciferase levels, further suggesting that the MAPK/ERK-dependent signaling pathway is the main activator of FAIM L transcription in PC12 cells (Fig. 3F ) . It should be noted that NGF treatment does not induce an increase in the levels of FAIM S transcription (data not shown). We could not detect changes in FAIM L expression in NGF-stimulated PC12 cells when the phosphatidyl inositol 3-kinase (PI3K)/Akt or NF-B pathways were blocked with LY294002 or the peptide SN50, respectively (data not shown).
FAIM L and FAIM S play different roles in the nervous system
Previous work of our laboratory demonstrated that FAIM S overexpression caused an increase in neurite length induced by NGF, both in PC12 cells and in SCG neurons, through the activation of the NF-B pathway. As such, reduction of endogenous FAIM S by RNAi significantly decreased NGF-stimulated neurite outgrowth from PC12 cells and SCG neurons . In contrast, when forced expression of FAIM L was tested in the same assays, no enhanced neurite outgrowth was observed (data not shown). However, the effects of endogenous FAIM L were not monitored and the possibility that FAIM L might be necessary for neurite formation was not ruled out. To test this hypothesis, we first analyzed the effect of FAIM L overexpression in the NF-B activity luciferase reporter assay. As shown in Figure 4 A, no increase in luciferase signal was detected after NGF treatment in FAIM Ltransfected cells (1.88 ϫ 10 5 Ϯ 0.61 ϫ 10 5 vs control cells, 2.88 ϫ 10 5 Ϯ 0.69 ϫ 10 5 ). However, a statistically significant increase in NF-B activity was observed in those transfected with FAIM S (4.47 ϫ 10 5 Ϯ 0.62 ϫ 10 5 vs control cells, 2.88 ϫ 10 5 Ϯ 0.69 ϫ 10 5 ) even in the absence of NGF (3.00 ϫ 10 5 Ϯ 0.09 ϫ 10 5 vs control cells, 1.11 ϫ 10 5 Ϯ 0.14 ϫ 10 5 ) (Fig. 4 A) . To further confirm that FAIM L has no role in neurite outgrowth, we generated specific short hairpin RNAi (shRNAi) constructs that target different sites of FAIM sequence, which could knock-down specifically FAIM L or FAIM S . RNAi n°1 (R1), which targeted exon 2, efficiently downregulated FAIM L as shown in Figure 4 B. RNAi n°2 targeted 19 nucleotides after the differential sequence between FAIM L and FAIM S . This construct minimally affects endogenous (Neo, N) , FLAG-tagged FAIM L (L), or FLAG-tagged FAIM S (S) were transfected with 1-2 g of the reporter vector for NF-B (HIV-LTR-Luciferase) by electroporation. Cells were stimulated with 100 ng/ml NGF for the indicated times or left untreated (NS, nonstimulated), and cell lysates were obtained with 50 l of Cell Culture Lysis Reagent (Luciferase Assay System Kit; Promega). Aliquots of supernatant were transferred to a standard 96-well plate for protein concentration determination using Protein Dye agent (Bio-Rad) following manufacturer instructions. Luciferase values were normalized to protein concentration (RLU/g of protein). The bottom panels show the control of the transgene expression by Western blot using a FLAG antibody. B, Scheme of FAIM L -and FAIM S -targeted RNAi design. Positions for the different RNAi are indicated, R1 is sequence specific for FAIM L , and R2 is in the common sequence and specifically silences the FAIM S (top panel). PC12 cells were infected with R1, R2, or RS (scrambled) for 72 h, and the effects on endogenous FAIM S/L expression were analyzed by Western blot with anti-FAIM antibodies (bottom panel). ␣-Tubulin was used as a loading control. C, PC12 cells were infected with the lentivirus expressing the RNAi constructs and GFP for 72 h and then treated with NGF (100 ng/ml) for one additional day. Representative images (top) show the inhibition of NGF-mediated neuritogenesis induced by the FAIM S -specific RNAi (R2). Both the scrambled (RS) and FAIM L -specific (R1) RNAi sequences resulted in similar NGFinduced neurite outgrowth as in control NI samples. The histogram shows the neurite length measurements of the GFP-positive cells and digitally acquired cultures infected with the indicated RNAi. **p Յ 0.01. Scale bar, 100 m.
FAIM L but efficiently downregulates FAIM S (Fig. 4 B, lane 4) . To analyze the effect of RNAi on neurite length, PC12 cells were infected with lentivirus carrying the vectors encoding for the different RNAi. After 72 h, the cells were treated with NGF (100 ng/ml) plus 0.5% HS for 1 d, and random pictures were taken in which the neurite length was measured. PC12 cells transduced with scrambled RNAi sequence developed neurite arbors identical to noninfected (NI) cells, indicating that lentiviral infection does not affect NGF-induced neurite outgrowth. Moreover, PC12 cells infected with R1 developed normal neurites indistinguishable from cells noninfected or infected with RS. As expected, PC12 cells infected with R2 significantly decreased their neurite length (133 Ϯ 18 m) compared with R1-infected cells (216 Ϯ 24 m) (Fig. 4C) .
FAIM L prevents death receptor-induced apoptosis in PC12 cell and cortical neurons
Because FAIM S was initially proposed to be a Fas antagonist (Schneider et al., 1999; Zhong et al., 2001) , we investigated whether FAIM L could have this role in the nervous system. According to previous data, FasL (Wu et al., 2004) or TNF␣ (Mielke and Herdegen, 2002) alone did not induce cell death in PC12 cells, whereas in combination with ActD (nM) they induced 25.85 Ϯ 0.62% of cell death for FasL and 26.41 Ϯ 0.28% for TNF␣ after 24 h of treatment, measured by counting the number of apoptotic nuclei after Hoechst staining (Fig. 5 A, B) . PC12 cells that overexpress FAIM L are completely resistant to FasL or TNF␣-induced apoptosis compared with control cells (Fig.  5 A, B) . Because caspase-8 has been defined as an apical caspase in both TNF␣ and Fas-induced cell death, the cleavage of the fluorescent peptide substrate z-IETDafc specific for caspase-8 was measured (Fig. 5C) . Treating PC12 cells with TNF␣ or ActD alone did not increase the IETDase activity, whereas cotreatment with TNF␣/ActD significantly enhances the activity. When the same experiment was done in PC12 cells overexpressing FAIM L , the IETDase activity was completely blocked in all conditions, including cells treated with TNF␣/ActD. Behavior of DEVDase activity (indicative of executor caspases 3/7) was similar to that observed with the IETDase activity (Fig. 5D) . In most cases, caspase-3 activation led to nuclear fragmentation, a well-known hallmark of apoptotic cell death. Figure 5E shows representative micrographs of Hoechst-stained cell nuclei from FAIM L overexpressing or mock-transfected (PC12-Neo) PC12 cells treated with TNF␣/ActD or untreated. After 24 h of treatment, nuclei from PC12-Neo cells appear rounded and fragmented, displaying a highly compacted chromatin and active Caspase-3 immunostaining (Fig. 5E, top right panel) . In contrast, PC12-FAIM L cells treated with TNF␣/ActD exhibit normal nuclei aspect with homogeneously stained chromatin when compared with untreated cells (Fig. 5E , bottom right and both left panels). In the same way, TNF␣/ActD-induced 3Ј-OH DNA ends Figure 5 . FAIM L overexpression protects PC12 cells from death receptor-induced cell death. Cell death was measured by counting condensed nuclei after Hoechst staining. PC12 cells were infected for 72 h with lentivirus carrying empty vector (Empty) or FAIM L (FAIM L ) and then were treated or not (C) with sFasL (100 ng/ml) (FasL) for an additional 24 h (A) or with TNF␣ (100 ng/ml) (TNF␣) or 24 h (B), alone or in combination with ActD (AD) (1 nM). C, Caspase activation was measured in the cell lysates after 12 h of the indicated treatments using z-IETD-afc for caspase 8 or in D, Ac-DEVD-afc for caspase-3 activity. Data were normalized by respect to untreated scrambled infected cells. Data are referred to the respective controls (n ϭ 3). E, Representative active caspase-3 immunofluorescence (in red) images were merged with Hoechst 33258 staining (in blue). Note that the typical apoptotic nuclear morphology and active caspase-3 staining only appears in empty-vector (Neo) PC12 cells treated with TNF␣/ ActD. Arrowheads point to apoptotic cells. F, Representative images of TUNEL staining are shown. PC12 cells overexpressing FAIM L (PC12-FAIM L ), but not those carrying an empty construct (PC12-Neo), were resistant to TNF␣/ActD treatment. Arrowheads indicate apoptotic nuclei. Scale bars, 25 m. G, Overexpression of FAIM S does not protect against TNF␣/ActD-induced apoptosis. Stable PC12 cell lines overexpressing empty vector (Neo), FAIM L , or FAIM S were treated and processed as indicated in B. *p Յ 0.05;**p Յ 0.01.
was only seen in PC12 cells transfected with the empty construct, because cells overexpressing FAIM L did not exhibit TUNEL positivity after the same treatment (Fig. 5F ). In contrast, when the overexpression of FAIM S was analyzed in the same system, no protection against TNF␣/ ActD-induced apoptosis was observed (Fig. 5G) . Similar results were obtained using primary cultures of cortical cells. As observed in PC12 cells, combined treatment with TNF␣/ActD induced apoptosis in mouse cortical neurons (Fig. 6 A) . Lentiviral-induced overexpression of FAIM L blocked death receptor-induced cell death, whereas the overexpression of FAIM S did not alter TNF␣/ActD-induced cell death. Accordingly, caspase-8 (Fig.  6 B) and caspase-3 (Fig. 6C ) activities, as well as cleaved caspase-3-positive neurons (Fig. 6 D) , were more abundant in empty vector-transduced neurons than in cultures infected with lentiviruses carrying the FAIM L construct. Moreover, as in PC12 cells, FAIM L -transduced cortical neurons did not display TUNEL positivity after TNF␣/ActD treatment (Fig. 6 E) .
FAIM L is an endogenous antagonist of death receptors
To further investigate the relevance of endogenous FAIM L , we used the shRNAi targeting system. PC12 cells were transiently infected with FAIM L RNAi (R1), and apoptotic cell death after death receptor triggering was measured by three different approaches: Hoechst staining, TUNEL assay, and immunofluorescence detection of active caspase-3. FAIM L -knocked-down PC12 cells acquired significant sensitivity to TNF␣-induced cell death without the need of treating the cells with ActD ( Fig.  7A-C) . As expected, PC12 cells infected with the scrambled RNAi sequence (RS) were resistant to TNF␣. To investigate the mechanism of prevention of TNF␣-mediated apoptosis by FAIM L in PC12 cells, we studied the role of caspases. Caspase-8 activity increased after TNF␣ treatment in FAIM L -knocked-down PC12 cells (3.73 Ϯ 0.41 vs nontreated cells, 1.52 Ϯ 0.05), whereas no activity was detected in scrambled-infected cells (1.23 Ϯ 0.09 vs nontreated cells, 1.0 Ϯ 0.07) (Fig.  7D ). These data confirm that FAIM L blocks death receptorinduced apoptosis at the level of or upstream caspase-8 activation. To confirm RNAi specificity, we reversed the RNAi (R1) effects using a construct expressing a silent mutated FAIM L (mut-FAIM L ). R1 RNAi was not efficient in reducing the levels of mut-FAIM L (Fig. 7E) . As shown in Figure 7F , the apoptotic cell death triggered by TNF␣ in FAIM L -knocked-down PC12 cells was almost completely reverted when these cells were infected with viruses carrying the mutFAIM L expression construct (empty vector transfected cells, 12.3% Ϯ 1.22 vs mutFAIML transfected cells, 5.57% Ϯ 0.37).
Motoneurons and cortical neurons use FAIM L as a endogenous antagonist of death receptors
To assess the physiological relevance of endogenous FAIM L in primary neuronal cells, we knocked-down FAIM L in primary neuronal cultures. It has been reported that cortical neurons acquire Fas sensitivity over time in culture (Cheema et al., 1999 ; Zuliani et al., 2006) , whereas they retain resistance to TNF␣ (Eves et al., 2001; Rickle et al., 2006) . R1-infected cortical neurons acquire TNF␣ and enhanced Fas sensitivity as assessed by analysis of the nuclear chromatin fragmentation after Hoechst staining [24.84 Ϯ 1.09% for TNF␣ and 23.74 Ϯ 1.09% for Jo2 in R1-infected cells vs 7.68 Ϯ 0.57% (TNF␣-treated) and 16.45 Ϯ 1.89 (Jo2-treated) in RS-infected cells] (Fig. 8 A, B) , TUNEL assay [33.85 Ϯ 2.70% for TNF␣ and 25.29 Ϯ 1.60% for Jo2 in R1-infected cells vs 11.04 Ϯ 1.77% (TNF␣-treated) and 13.29 Ϯ 0.62 (Jo2-treated) in RS-infected cells] (Fig. 8C,D) and trypan blue exclusion assay (data not shown). To confirm these results in a well-characterized cellular model where DRs have been shown to have a relevant function (Raoul et al., 2002; Demjen et al., 2004; Raoul et al., 2006; Wen et al., 2006) , we performed a series of comparable experiments using spinal cord motoneurons. Motoneurons infected with the R1 sequence show an increase of apoptotic cell death compared with the scrambled infected cells after either Fas or TNFR1 engagement (23.12 Ϯ 4.33% for control cells; 39.76 Ϯ 4.40% for R1/TNF-treated cells, and 47.39 Ϯ 4.60% for R1/Fastreated cells) (Fig. 8 E, F ) . Altogether, these results confirm the physiological implication of FAIM L in neuronal resistance against death receptor-triggered apoptosis, placing it as a new intracellular player in the regulation of cellular responses during nervous system development. (Fig. 9B) . In contrast, FAIM S failed to coimmunoprecipitate with Fas, irrespectively of the presence of FasL in the culture media (Fig. 9A,B) . The interaction between endogenous FAIM L and Fas was confirmed in PC12 cells. The specific immunoprecipitation of Fas from untreated PC12 cell lysates shows that endogenous FAIM L interacts with this DR. As expected, control iso-specific immunoglobulin (IgG) failed to immunoprecipitate Fas and, in consequence, FAIM L (Fig. 9C ). In the same way, FAIM L was also able to interact with endogenous Fas in PC12 cells overexpressing FAIM L (Fig. 9C) . To assess whether the adaptor protein FADD could revert the interaction between FAIM L and Fas, we performed combined transfections of FLAG-FAIM L with HA-FADD, Fas, or both. As shown in Figure 9D , the overexpression of FADD fully prevented the interaction between FAIM L and Fas, although Fas was expressed at high levels (Fig. 9D) . These data, together with the anti-apoptotic role of FAIM L , suggest that this protein must block DR-triggered apoptotic cell death at the level of the DR complex.
Discussion
Signaling pathways controlling neuronal death and survival are crucial for the normal development and function of the nervous fact, it has been demonstrated that FLIP is not responsible in mediating Fas-resistance in vitro cultured embryonic neurons (Beier et al., 2005) . Because it has been demonstrated that both death ligands (DLs) and DRs are expressed during the neuronal development (Cheema et al., 1999) and in the adult brain (Bette et al., 2003; Choi and Benveniste, 2004) , other intracellular regulators distinct of FLIP that are able to antagonize DR-mediated cell death must exist.
Another molecule described as an antagonist of death receptors in the nervous system is LFG (also known as neuronal membrane protein 35, NMP35) (Somia et al., 1999; Schweitzer et al., 2002; Beier et al., 2005; Fernández et al., 2007) . LFG is predominantly expressed in the nervous system (Schweitzer et al., 2002) and has been shown to be the molecule responsible for Fas death resistance in cerebellar granule neurons (Beier et al., 2005; Fernández et al., 2007) . However, a relevant difference with FAIM L is that LFG is not able to protect from death induced by TNF␣ (Somia et al., 1999) . Whereas expression of FAIM L is maximal during embryonic or early postnatal stages, the expression of LFG continuously increases during development and reaches maximal levels in the adult (Schweitzer et al., 2002) . This suggests that LFG could be more significant in neuronal injuries that occur in the adult.
Neurotrophins exert their anti-apoptotic function by the activation of diverse intracellular pathways. One of the main mechanisms involved in the cellular resistance to DR-triggered apoptosis is the transcriptional regulation of DR modulators (Tran et al., 2004) . In this way, the activation of the MAPK/ERK pathway suppresses Fas-mediated apoptosis in diverse cellular systems (Tran et al., 2001) . We observed that NGF activates FAIM L promoter through the activation of the MAPK/ERK pathway in PC12 cells. In contrast, LFG is regulated by PI3K-Akt/protein kinase B (Beier et al., 2005) , and c-FLIP is mainly controlled by NF-B (Okano et al., 2003; Xiao et al., 2003) . FAIM L expression was unaffected by the inhibition of these pathways. Neither the PI3K inhibitor LY294002 nor the p65 SN50 inhibitor for NF-B modified NGF-regulation of the FAIM L promoter in PC12 cells (data not shown).
Here, we show that the overexpression of FAIM L abolishes DR-induced caspase-8 activation and, therefore, apoptotic cell death in PC12 cells and in embryonic primary neurons. Moreover, the knock-down of endogenous FAIM L sensitizes embryonic neurons to apoptosis mediated by DR engagement, in a caspase-8-dependent manner. Altogether, these data suggest that the inhibition of DR-induced caspase-8 activation depends on the levels of anti-apoptotic molecules like FAIM L . In Figure 9 , we show that in basal conditions, FAIM L , but not FAIM S , is able to interact with Fas. This interaction is no longer observed when cells were treated with FasL, therefore suggesting that activation of the receptor displaces the binding of FAIM L . Furthermore, we show that FADD competes with FAIM L for the binding to Fas. This behavior is similar to what was reported for the silencer of death domains (SODD) (Jiang et al., 1999; Tschopp et al., 1999) . SODD is a widely expressed protein that is normally associated with the death domain of TNF-R1 or DR3. When the receptor is stimulated, SODD is released, permitting the recruitment of TRADD (TNF receptor-associated death domain) and TRAF2 (TNF receptor-associated factor 2) to the active receptor (Jiang et al., 1999) . However, the mice without SODD develop normally and do not show any major defects in death receptor signaling, thus suggesting the existence of other redundant gene (Endres et al., 2003) . Although we have not completely characterized the mechanisms of FAIM L antagonism and FAIM L and SODD are not structurally related, our results favor the view that FAIM L could be a SODD-like molecule specifically expressed in the nervous system.
We reported that FAIM L is upregulated during the embryonic stages when DLs and DRs like Fas/FasL or TNF-RI and RII/TNF␣ are expressed in neuronal regions that do not show increased apoptosis (Nadeau and Rivest, 1999; Kovac et al., 2002) . In this regard, we observe that FAIM L upregulation strongly correlates with the neuronal expression of DRs such as TNF-RI, TNF-RII (Bette et al., 2003) , and Fas (Zuliani et al., 2006) . For instance, Fas is expressed at E15 and its levels are maintained until early postnatal stages. FAIM L and Fas share similar expression patterns that are particularly strong in the hippocampus, cerebellum, and cortical layers II-III and V of the neocortex, specially in pyramidal . After 24 h, lysates were performed and subjected to immunoprecipitation using FLAG-specific mAb M2-coupled agarose beads (Sigma). The immunoprecipitates (eluted fractions) were resolved by SDS-PAGE, and proteins were transferred onto PVDF membranes and immunoblotted with anti-Fas (top panels) or anti-FLAG (M2) (bottom panel) antibodies. All membranes were also stained with Naphtol Blue to confirm equal loading (middle panels). B, HEK293T cells transfected as in A were left untreated or treated with soluble FasL (sFasL). Western blots were performed as stated for A. C, One milligram of PC12 cell lysate was immunoprecipitated (IP) with anti-Fas antibody (Fas) followed by Western blot with either FAIM L (top panels) or Fas (bottom panels) antibodies. A nonrelevant iso-specific antibody (IgG) was used as a negative control. D, PC12 cells were transiently transfected with different constructions carrying FLAG-FAIM L , FLAG-FAIM S , HA-FADD, and/or pcDNA3-mFas (Fas) . After 48 h, immunoprecipitation and Western blot analysis were performed as in A. Blotting the membranes with anti-HA confirmed the PC12 cells transfection with the HA-FADD construct. When FADD was overexpressed, there was no longer any interaction between FAIM L and Fas.
neurons (Zuliani et al., 2006 ). We also demonstrate that FAIM L is a powerful inhibitor of apoptosis mediated by the activation of DRs such as Fas and TNF-Rs. Therefore, we can argue that FAIM L could be a key modulator of DR-triggered apoptosis during development of different embryonic neuronal populations of the CNS.
Other functions have been proposed for the expression of the Fas-FasL system during development of the nervous system. Thus, for example, Fas engagement has been shown to induce neurite outgrowth in dorsal root ganglion neurons in vitro and promote the functional recovery in vivo of transacted sciatic nerves (Desbarats et al., 2003) . Similarly, the Fas-FasL system has been involved in controlling neuronal branching, and, importantly, both lpr and gld mice show reduced dendritic branching during development (Zuliani et al., 2006) . These effects are caspase independent. Because FAIM L does not regulate classical survival/differentiation pathways such as PI-3K, NF-B, or ERK/ MAPK activated by neurotrophins, it is tempting to speculate that the anti-apoptotic function of FAIM L may act as a critical switch on the biological consequences derived from DR triggering, overriding the apoptotic death cascades.
In summary, we provide, for the first time, the involvement of the splice variant of the anti-apoptotic protein FAIM in the regulation of DR-triggered neuronal death. FAIM L overexpression blocks DR-induced cell death, and the endogenous protein is required for neuronal resistance against DR-mediated apoptosis. This mode of action strictly depends on the inhibition of apical caspases, like caspase-8, at the level of the receptor complex.
